Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Therefore, the aim of the current research was to investigate the effects of in ovo and dietary sources of 25OHD3 in conjunction with the in ovo delivery of the MVD on the broiler meat yield, live performance, and incidence of woody breast myopathy (WBM).
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Effects of the Marek’s Disease Vaccine on the Performance, Meat Yield, and Incidence of Woody Breast Myopathy in Ross 708 Broilers When Administered Alone or in Conjunction with In ovo and Dietary Supplemental 25-Hydroxycholecalciferol
Study design awaiting verification · Animals : an Open Access Journal from MDPI · 2024
Original publication title
Effects of the Marek’s Disease Vaccine on the Performance, Meat Yield, and Incidence of Woody Breast Myopathy in Ross 708 Broilers When Administered Alone or in Conjunction with In ovo and Dietary Supplemental 25-Hydroxycholecalciferol
© 2024 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: Simple Summary
The second metabolite of vitamin D, 25-hydroxyvitamin D3 (25OHD3), has previously shown promising results on the live performance and meat yield of broilers when it was administered in ovo or in their diet. However, the effects of 25OHD3 on the posthatch performance of broilers have not been tested in combination with the in ovo administration of the Marek’s disease vaccine (MDV). Therefore, the aim of the current research was to investigate the effects of in ovo and dietary sources of 25OHD3 in conjunction with the in ovo delivery of the MVD on the broiler meat yield, live performance, and incidence of woody breast myopathy (WBM).
In this study, it was shown that both 25OHD3 sources increased the meat yield and improved the live performance variables of broilers with no measurable negative effects on WBM scoring. It is worth mentioning that the dietary source of 25OHD3 had greater effects on breast meat yield and posthatch performance throughout the rearing period when compared to its in ovo administration. In conclusion, both the in ovo and dietary administration of 25OHD3 can be used in combination with the in ovo delivery of the MDV in order to enhance its efficacy on broiler posthatch production.
Source: Simple SummaryAbstract: Abstract
The effects of the Marek’s disease vaccine (MDV) on the live performance, breast meat yield, and incidence of woody breast myopathy (WBM) of Ross 708 broilers were investigated when administered alone or in conjunction with in ovo and dietary supplemental 25-hydroxycholecalciferol (25OHD3). At 18 d of incubation (doi), four in ovo injection treatments were randomly assigned to live embryonated Ross 708 broiler hatching eggs: (1) non-injected; (2) commercial MDV alone; or MDV containing either (3) 1.2 or (4) 2.4 μg of 25OHD3.
An Inovoject multi-egg injector was used to inject a 50 μL solution volume into each egg. The birds were provided a commercial diet that contained 250 IU of cholecalciferol/kg of feed (control) or a commercial diet that was supplemented with an additional 2760 IU of 25OHD3/kg of feed (HyD-diet). In the growout period, 14 male broilers were placed in each of 48 floor pens resulting 6 replicated pens per in ovo x dietary treatment combination. Live performance variable were measured at each dietary phases from 0 to 14, 15 to 28, and 29 to 40 d of age (doa).
At 14 and 40 doa, pectoralis major (P. major) and pectoralis minor (P. minor) muscles were determined for one bird within each of the six replicate pens. At 41 doa, WBM incidence was determined. No significant main or interaction effects occurred for WBM among the dietary or in ovo injection treatments. However, in response to in ovo 25OHD3 supplementation, BW and BWG in the 29 to 40 doa period and BWG and FCR in the 0 to 40 doa period improved.
In addition, at 40 and 41 doa, breast meat yield increased in response to in ovo and dietary 25OHD3 supplementation. Future research is needed to determine the possible reasons that may have been involved in the aforementioned improvements.
Source: AbstractAuthors’ abstract
Simple Summary
The second metabolite of vitamin D, 25-hydroxyvitamin D3 (25OHD3), has previously shown promising results on the live performance and meat yield of broilers when it was administered in ovo or in their diet. However, the effects of 25OHD3 on the posthatch performance of broilers have not been tested in combination with the in ovo administration of the Marek’s disease vaccine (MDV). Therefore, the aim of the current research was to investigate the effects of in ovo and dietary sources of 25OHD3 in conjunction with the in ovo delivery of the MVD on the broiler meat yield, live performance, and incidence of woody breast myopathy (WBM).
In this study, it was shown that both 25OHD3 sources increased the meat yield and improved the live performance variables of broilers with no measurable negative effects on WBM scoring. It is worth mentioning that the dietary source of 25OHD3 had greater effects on breast meat yield and posthatch performance throughout the rearing period when compared to its in ovo administration. In conclusion, both the in ovo and dietary administration of 25OHD3 can be used in combination with the in ovo delivery of the MDV in order to enhance its efficacy on broiler posthatch production.
Abstract
The effects of the Marek’s disease vaccine (MDV) on the live performance, breast meat yield, and incidence of woody breast myopathy (WBM) of Ross 708 broilers were investigated when administered alone or in conjunction with in ovo and dietary supplemental 25-hydroxycholecalciferol (25OHD3). At 18 d of incubation (doi), four in ovo injection treatments were randomly assigned to live embryonated Ross 708 broiler hatching eggs: (1) non-injected; (2) commercial MDV alone; or MDV containing either (3) 1.2 or (4) 2.4 μg of 25OHD3.
An Inovoject multi-egg injector was used to inject a 50 μL solution volume into each egg. The birds were provided a commercial diet that contained 250 IU of cholecalciferol/kg of feed (control) or a commercial diet that was supplemented with an additional 2760 IU of 25OHD3/kg of feed (HyD-diet). In the growout period, 14 male broilers were placed in each of 48 floor pens resulting 6 replicated pens per in ovo x dietary treatment combination. Live performance variable were measured at each dietary phases from 0 to 14, 15 to 28, and 29 to 40 d of age (doa).
At 14 and 40 doa, pectoralis major (P. major) and pectoralis minor (P. minor) muscles were determined for one bird within each of the six replicate pens. At 41 doa, WBM incidence was determined. No significant main or interaction effects occurred for WBM among the dietary or in ovo injection treatments. However, in response to in ovo 25OHD3 supplementation, BW and BWG in the 29 to 40 doa period and BWG and FCR in the 0 to 40 doa period improved.
In addition, at 40 and 41 doa, breast meat yield increased in response to in ovo and dietary 25OHD3 supplementation. Future research is needed to determine the possible reasons that may have been involved in the aforementioned improvements.
Publication and source details
Original title: Effects of the Marek’s Disease Vaccine on the Performance, Meat Yield, and Incidence of Woody Breast Myopathy in Ross 708 Broilers When Administered Alone or in Conjunction with In ovo and Dietary Supplemental 25-Hydroxycholecalciferol
Seyed Abolghasem Fatemi; Ayoub Mousstaaid; Christopher J. Williams; Joshua Deines; Sabin Poudel; Ishab Poudel; Elianna Rice Walters; April Waguespack Levy; Edgar David Peebles
Animals : an Open Access Journal from MDPI · 2024
* Correspondence: sf1006@msstate.edu© 2024 by the authors.2024https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).United States Department of Agriculture58-6406-4-016Zoetis Animal Health Co.DSM Nutritional Products Inc.The United States Department of Agriculture (USDA agreement no. 58-6406-4-016) Zoetis Animal Health Co. and DSM Nutritional Products Inc. supported this research.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T04:43:26.986335+00:00
DOI: 10.3390/ani14091308 · PMC11083642